• A bibliometric analysis of follicular thyroid carcinoma: Current situation, hot spots, and global trends
• A machine learning model utilizing delphian lymph node characteristics to predict contralateral central lymph node metastasis in papillary thyroid carcinoma: A prospective multicenter study
• A rare case of concurrent papillary thyroid carcinoma and occult follicular carcinoma: Case report and discussion of surgical management strategies
• A review of complex hormone regulation in thyroid cancer: novel insights beyond the hypothalamus-pituitary-thyroid axis
• Advances in clinical research on ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma
• Analysis of Immunohistochemical Expression of BRAF (V600E) Mutation in Serrated Colorectal Polyps: A Study from Tertiary Hospital in Oman
• Analysis of risk factors for lymph node metastasis in patients with CN0 papillary thyroid carcinoma
• Apparently Benign 131I Adrenal Uptake
• ASO Author Reflections: Equal Access to Medical Care and Racial and Ethnic Disparities in the Management of Papillary Thyroid Cancer
• Biomarkers related to m6A and succinic acid metabolism in papillary thyroid carcinoma
• BRAFV600E/ p-ERK/ p-DRP1(Ser616) Promotes Tumor Progression and Reprogramming of Glucose Metabolism in Papillary Thyroid Cancer
• Case report: An adolescent female with anosmic hypogonadotropic hypogonadism, intellectual disability, and papillary thyroid carcinoma: heterozygous deletion of TCF12
• CD36+ pro-inflammatory macrophages interact with ZCCHC12+ tumor cells in papillary thyroid cancer promoting tumor progression and recurrence
• Cheminformatics-based identification of phosphorylated RET tyrosine kinase inhibitors for human cancer
• circ_BACH2 affects the malignant biological behavior of papillary thyroid cancer by regulating miR-370-3p
• Circ-METTL15 stimulates the aggressive behaviors of papillary thyroid cancer cells by coordinating the miR-200c-3p/XIAP axis
• Clinical features and Surgical Outcomes of Thyroid Goitre Presenting to Ear, Nose and Throat Department of Queen Elizabeth Central Hospital, Blantyre, Malawi
• Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report
• Clinical, Pathological, and Immunohistochemical Predictors of Cause-Specific Mortality in Papillary Thyroid Cancer: Multivariate Analysis
• Clinicopathological features affecting the efficacy in (131)I ablation therapy of papillary thyroid carcinoma with lymph node metastasis
• Clinicopathological parameters associated with cervical lymph node metastases in differentiated thyroid cancer
• Comment on 'Therapeutic targeting of TNIK in papillary thyroid carcinoma: a novel approach for tumor growth suppression'
• Comparison between thermal ablation and surgery in low risk papillary thyroid carcinoma: a prospective study
• Complimentary Role of [18F]FDG and [18F]NaF-PET/CT in Evaluating Synchronous Thyroid Carcinoma and Parathyroid Adenoma with Brown Tumors
• Comprehensive genomic profiling of infiltrative follicular variant of papillary thyroid carcinoma
• Cross-section of thyroidology and nephrology: Literature review and key points for clinicians
• CXCL5 expression is associated with active signals of macrophages in the microenvironment of papillary thyroid carcinoma
• Decorin impeded the advancement of thyroid papillary carcinoma by thwarting the EGFR/ FER/ SHP2 signaling-induced sustenance of early endosomes
• Decreased Sirtuin 4 Levels Promote Cellular Proliferation and Invasion in Papillary Thyroid Carcinoma
• Detection of RAS p.Q61R by Immunohistochemistry in Practice: A Clinicopathologic Study of 217 Thyroid Nodules with Molecular Correlates
• Efficacy and Safety of Thermal Ablation for Solitary Low-Risk T2N0M0 Papillary Thyroid Carcinoma
• Elevations of neutrophil-to-lymphocyte ratio and C-reactive protein over time as a precursor to anaplastic transformation of papillary thyroid carcinoma: a case report
• Evaluation of reference genes suitable for studying mRNAs and microRNAs expression in thyroid neoplasms
• Exploring markers of immunoresponsiveness in papillary thyroid carcinoma and future treatment strategies
• Exploring Radiofrequency Ablation for T1 Papillary Thyroid Cancer in the United States: Mayo Clinic Experience
• Exploring the Therapeutic Potential of Extracellular Vesicles Derived from Human Immature Dental Pulp Cells on Papillary Thyroid Cancer
• Feasibility of completion thyroidectomy via transoral endoscopic vestibular approach
• First-Generation Radiolabeled Cyclic Peptides for Molecular Imaging of Platelet-Derived Growth Factor Receptor α
• From sequencing to validation: NGS-based exploration of plasma miRNA in papillary thyroid carcinoma
• Higher microRNA-221 and lower microRNA-451 expression are associated with poor prognosis in patients with thyroid papillary carcinoma
• Identification of mechanism of the oncogenic role of FGFR1 in papillary thyroid carcinoma
• Identification of serum metabolites associated with polybrominated diphenyl ethers (PBDEs) exposure in papillary thyroid carcinoma: a case-control study
• Incidence of Persistence and Recurrence of Differentiated Thyroid Cancer in Post-surgical Cases From a Tertiary Care Hospital in Dubai, United Arab Emirates
• Incomplete ablation of thyroid cancer: Achilles' Heel?
• Infiltration of nanocarbon into the trachea during thyroidectomy surgery: case series and literature review
• Initial clinical experience using (68)Ga-FAPI-46 PET/CT for detecting various cancer types
• Interstitial Fibrosis as a Common Counterpart of Histopathological Risk Factors in Papillary Thyroid Microcarcinoma: A Retrospective Analysis
• Intraglandular dissemination: a special pathological feature
• LncRNA LINC00969 modified by METTL3 attenuates papillary thyroid cancer progression in an m6A-dependent manner
• Long-term efficacy of lobectomy for stage T1 papillary thyroid carcinoma with varying degrees of lymph node metastasis
• Low-dose ionizing radiation-induced RET/PTC1 rearrangement via the non-homologous end joining pathway to drive thyroid cancer
• Mechanism of DAPK1 for Regulating Cancer Stem Cells in Thyroid Cancer
• Microwave ablation for lymph node metastasis in thyroid cancer: the impact of lymph node diameter
• Minimally Invasive Open Bilateral Total Thyroidectomy Using Unilateral Neck Incision in Thyroid Cancer: Preliminary Surgical and Quality of Life Outcomes
• Mitochondrial DNA copy number and risk of papillary thyroid carcinoma
• Neoadjuvant treatment with lenvatinib and pembrolizumab in a BRAF V600E-mutated anaplastic thyroid cancer: a case report
• Occult Thyroid Carcinoma with Cervical Lymph Node Metastasis: A Rare Case Report
• Outcomes of Differentiated Thyroid Cancer in Children and Adolescents at King Abdulaziz Medical City, Jeddah
• Papillary thyroid cancer and cutaneous melanoma: An often underrecognized pair
• Papillary Thyroid Cancer in a Patient With Graves' Disease and Hyperfunctioning (Hot) Thyroid Nodules: An Unexpected Presentation
• Papillary thyroid carcinoma with invasion of the trachea
• Papillary Thyroid Carcinoma, Cushing Disease, and Adrenocortical Carcinoma in a Patient with Li-Fraumeni Syndrome
• Papillary thyroid microcarcinoma: Does management differ based on facility variables?
• PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entities
• PD-L1 and B7-H3 are Effective Prognostic Factors and Potential Therapeutic Targets for High-Risk Thyroid Cancer
• Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine
• Plasma miRNA-146b-3p, -222-3p, -221-5p, -21a-3p Expression Levels and TSHR Methylation: Diagnostic Potential and Association with Clinical and Pathological Features in Papillary Thyroid Cancer
• POU5F1B is responsible for the acquired resistance to dabrafenib in papillary thyroid cancer cells with the BRAF V600E mutation
• Predicting central lymph node metastasis in papillary thyroid cancer: A nomogram based on clinical, ultrasound and contrast-enhanced computed tomography characteristics
• Preoperative Evaluation of Cervical Lymph Node Metastasis in Patients With Hashimoto's Thyroiditis Combined With Thyroid Papillary Carcinoma Using Machine Learning and Radiomics-Based Features: A Preliminary Study
• Preoperative Ultrasonography Predicts Level II Lymph Node Metastasis in N1b Papillary Thyroid Carcinoma: Implications for Surgical Planning
• Prevalence of Papillary Thyroid Carcinoma is Significantly Higher in Graves Disease with Synchronous Thyroid Nodules
• Prognostic implications of lymph node yield in pediatric patients with N1b papillary thyroid cancer
• Prognostic nutritional index predicts lateral lymph node metastasis and recurrence free survival in papillary thyroid carcinoma
• Prognostic significance of metastatic lymph node size and extra-nodal extension in papillary thyroid carcinoma according to the 9th edition of general rules for the description of thyroid cancer risk stratification: a single center validation study
• Prophylactic Central Compartment Dissection on the Long-Term Outcome of Advanced (N0-T3/T4) Papillary Thyroid Cancer
• Racial-Ethnic Comparison of Treatment for Papillary Thyroid Cancer in the Military Health System
• Review of retropharyngeal and parapharyngeal nodal metastasis of papillary thyroid carcinoma
• Role of Locoregional Therapies in the Treatment of Thyroid Pathology: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel
• SGLT-2 inhibitors are beneficial in reducing the risk of thyroid cancer: findings from a Mendelian randomization study
• Significance of incidental thyroid 18F-fluorocholine uptake in patients with hyperparathyroidism imaged for localizing hyperfunctioning parathyroid glands
• Simultaneous occurrence of papillary thyroid carcinoma, medullary thyroid carcinoma, and lymphoma: A case report
• Surgical management of papillary thyroid carcinoma coexisting with Hashimoto's disease: a single-center retrospective cohort study
• TG-IGF1R: A Novel Receptor Tyrosine Kinase Fusion Oncogene in Pediatric Thyroid Cancer
• The association between thyroid differentiation score and survival outcomes in papillary thyroid carcinoma
• The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma?
• The common pathogenesis of nodular goiter in both sexes: An exploration into gene expression and signaling pathways
• The effects of iodine 131 treatment on chromosomal and oxidative DNA damage in papillary thyroid carcinoma
• The impact of Hashimoto's thyroiditis on the clinical outcome of papillary thyroid cancer after radioactive iodine therapy: a propensity score matching study
• The influence of cancer on the reprogramming of lipid metabolism in healthy thyroid tissues of patients with papillary thyroid carcinoma
• The role of immune cells and immune related genes in the tumor microenvironment of papillary thyroid cancer and their significance for immunotherapy
• The Sex and Age-Associated Infiltration of B Cells May Result in the Dimorphic Behaviors Observed in Papillary Thyroid Carcinomas
• Thy-DAMP: deep artificial neural network model for prediction of thyroid cancer mortality
• Thyroid Paraganglioma: A Rare Manifestation of Paraganglioma Syndrome Associated With Pathogenic Variant in SDHD
• TIMP1 promotes thyroid cancer cell progression through macrophage phenotypic polarization via the PI3K/AKT signaling pathway
• TMEM252 inhibits epithelial-mesenchymal transition and progression in papillary thyroid carcinoma by regulating Notch1 expression
• Treatment of Unresectable BRAF V600E, TERT-Mutated Differentiated Papillary Thyroid Cancer With Dabrafenib and Trametinib
• Trends in papillary thyroid cancer mortality in Denmark according to stage and education
• Two Rare Cases of Metastatic Occult Thyroid Carcinoma Without Primary Cancer in the Thyroid Gland
• Vernodalin Triggers ROS-Mediated Apoptosis in TPC-1 Human PapillaryThyroid Cancer Cells via Suppression of the MAPKs Signaling Pathway